Skip to content

Clover Health

US · CLOV #2665 by market cap Listed 1970
4.56 -0.04 -0.87%
Live - 5344 symbols - heartbeat 548s ago · 2026-10-08 05:51
Pre-market 4.56 0.00%
After-hours 4.60 +0.82%
Overnight 4.60 +0.88%
Market cap
2.42B
P/B
6.44
EPS
-0.17
Reader sentiment Are you bullish or bearish on CLOV?

Anonymous reader poll. Unscientific, not investment advice.

Recent news

  • Rating change
    CCORF Maintains Clover Health(CLOV.US) With Buy Rating, Maintains Target Price $3.2
    Market Newswire · 2026/5/7
  • CCORF Maintains Clover Health(CLOV.US) With Buy Rating, Raises Target Price to $5.5
    Market Newswire · 2026/7/22
  • Rating change
    Craig-Hallum Maintains Clover Health(CLOV.US) With Buy Rating
    Market Newswire · 2025/10/10
  • Rating change
    CCORF Maintains Clover Health(CLOV.US) With Buy Rating, Maintains Target Price $4.1
    Market Newswire · 2025/9/8
  • Rating change
    CCORF Maintains Clover Health(CLOV.US) With Buy Rating, Cuts Target Price to $3.2
    Market Newswire · 2026/3/20
  • Deutsche Bank Initiates Clover Health(CLOV.US) With Buy Rating, Announces Target Price $6
    Market Newswire · 2026/9/10
  • CCORF Maintains Clover Health(CLOV.US) With Buy Rating, Maintains Target Price $5.5
    Market Newswire · 2026/8/12
  • Rating change
    Craig-Hallum Maintains Clover Health(CLOV.US) With Buy Rating, Announces Target Price $5
    Market Newswire · 2025/8/7
  • Rating change
    Leerink Partners Maintains Clover Health(CLOV.US) With Hold Rating, Raises Target Price to $3
    Market Newswire · 2025/10/22
  • Rating change
    CCORF Maintains Clover Health(CLOV.US) With Buy Rating, Maintains Target Price $4.5
    Market Newswire · 2025/5/8
  • Rating change
    UBS Maintains Clover Health(CLOV.US) With Hold Rating, Cuts Target Price to $2.75
    Market Newswire · 2026/2/27
  • Rating change
    UBS Maintains Clover Health(CLOV.US) With Hold Rating, Cuts Target Price to $3
    Market Newswire · 2025/8/7
  • Rating change
    Leerink Partners Maintains Clover Health(CLOV.US) With Hold Rating, Cuts Target Price to $2.5
    Market Newswire · 2025/8/9
  • Rating change
    CCORF Maintains Clover Health(CLOV.US) With Buy Rating, Cuts Target Price to $4.1
    Market Newswire · 2025/8/7
  • Rating change
    CCORF Maintains Clover Health(CLOV.US) With Buy Rating, Cuts Target Price to $3.7
    Market Newswire · 2025/11/6
  • Deutsche Bank Maintains Clover Health(CLOV.US) With Buy Rating, Maintains Target Price $6
    Market Newswire · 2026/9/11
  • Rating change
    Leerink Partners Maintains Clover Health(CLOV.US) With Hold Rating, Maintains Target Price $2.5
    Market Newswire · 2025/8/12
  • CCORF Maintains Clover Health(CLOV.US) With Buy Rating, Raises Target Price to $4.2
    Market Newswire · 2026/6/4
  • Rating change
    Analysts Offer Insights on Healthcare Companies: Lexeo Therapeutics, Inc. (LXEO), Clover Health Investments (CLOV) and Xilio Therapeutics (XLO)
    TipRanks · 2025/8/15
  • Rating change
    CCORF Maintains Clover Health(CLOV.US) With Buy Rating, Maintains Target Price $3.7
    Market Newswire · 2026/2/28

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-10-08 05:51:28 · For reference only, not investment advice and not tailored to your situation.